HomePortfoliosJordy High Growth Portfolio definitief.

Jordy High Growth Portfolio definitief.

None Rebalancing
EUR
Moderate Risk
3.0yr backtest

Performance Summary

Total Return+104.36%
Annualized Return+27.34%
Volatility+18.15%
Sharpe Ratio1.40
Max Drawdown+25.98%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
US equity & tech-focused ETF portfolio with S&P 500, semiconductor, nuclear, and cybersecurity holdings for targeted growth.
AssetTypeAllocationTER
SPYL.XETRA
State Street SPDR S&P 500 UCITS ETF USD Unhedged (Acc) • IE000XZSV718
ETF
66.7%0.03%
VVSM.XETRA
VanEck Semiconductor UCITS ETF • IE00BMC38736
ETF
13.3%0.35%
NUKL.XETRA
VanEck Uranium and Nuclear Technologies UCITS ETF A • IE000M7V94E1
ETF
10.0%0.55%
L0CK.XETRA
iShares Digital Security UCITS ETF USD (Acc) • IE00BG0J4C88
ETF
10.0%0.4%
Total100.0%0.16%

Performance

Portfolio Value Over Time
Starting with €10,000 investment → now worth €20,435.85
Histogram of Monthly Returns
The portfolio had a positive return during 23 of the 36 months (64%)
Monthly Returns Heatmap
Best month: +14.5% • Worst month: -9.9% • Best year: 2024 (+31.7%) • Worst year: 2023 (+11.1%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+4.7%-0.7%-5.7%+14.5%+9.7%+3.0%-6.6%+2.9%+4.5%-3.0%--+23.7%
2025+4.3%-5.4%-9.9%-4.0%+10.1%+4.0%+6.3%-1.2%+5.9%+8.1%-4.0%+0.1%+12.9%
2024+5.0%+4.7%+3.9%-2.4%+1.5%+7.0%-1.8%-1.3%+2.3%+3.0%+8.2%-1.6%+31.7%
2023----------+5.9%+4.9%+11.1%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +25.98% • The longest drawdown period lasted for 7 months and was between January 2025 and September 2025. It reached a trough of -26.0%.

Detailed Metrics

Returns
Total Return
+104.36%
Annualized Return
+27.34%
Avg Monthly Return
+2.14%
Risk
Volatility (Annual)
+18.15%
Max Drawdown
+25.98%
Positive Months
64%
Average Drawdown
-4.1%
Risk-Adjusted
Sharpe Ratio
1.40
Risk-free rate: 2.0%
Sortino Ratio
1.34
Downside risk adjusted
Return/Volatility
1.51
Calmar Ratio
1.05
Return/Max Drawdown
Ulcer Index
5.57
Drawdown depth & duration
Martin Ratio
0.05
Return/Ulcer Index
Backtest Configuration
Initial Investment
€10,000
Final Value
€20,435.85
Backtest Period
2023-11-01 to 2026-10-16
3.0 years
Rebalancing
none
Base Currency
EUR